SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Acquisition

1 May 2015 07:00

RNS Number : 9497L
Oxford Instruments PLC
01 May 2015
 



 

Release date: 1 May 2015

 

Oxford Instruments plc

Acquisition of Medical Imaging Resources, Inc.

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

 

Founded in 1990 in Ann Arbor Michigan by CEO John Vartanian, MIR specialises in the build, lease and service of mobile medical imaging labs ("mobiles").

 

The mobile labs are built in MIR's factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba. These are leased to customers across the USA. MIR is also responsible for servicing its mobiles. Customers include hospitals and clinics that need additional capacity or that wish to trial MRI or CT machines without committing to the infrastructure and cost associated with a permanent unit.

 

MIR will form a part of OIHealthcare, within the Group's Service sector, which already services GE MRI and CT machines in the USA. There are a number of synergies with OIHealthcare:

 

· This will be a significant step to making OIHealthcare a multi-skilled independent service provider able to support large individual service contracts;

· Access to OIHealthcare's parts and its purchasing power for complete systems will lower MIR's operating costs;

· There will be overheads savings in those areas where duplication is eliminated;

· MIR currently sub-contracts a significant portion of the service work for its mobiles. OIHealthcare staff are located in numerous states and once trained will take over the work and will be able to bring the margin in-house.

 

Consideration, which will be satisfied from existing facilities, comprises $10.4 million (c. £6.8 million) on completion followed by a further $10.1 million (c. £6.6 million) earn-out payable one year later. MIR has approximately $3.0 million (c. £2.0 million) net debt at completion.

 

In the year to 31 December 2014, MIR had sales of $16.6 million (c. £10.8 million), profit before tax of $2.8 million (c. £1.8 million) and EBITDA of $5.6 million (c. £3.6 million). At 31 December 2014, MIR had gross assets of $9.4 million (c. £6.1 million).

 

 

 

Jonathan Flint (Chief Executive) and Kevin Boyd (Finance Director) will host a conference call for analysts and investors on this announcement at 9:30 am (UK time), today 1 May. To join the call, please use the dial-in numbers below:

 

Dial: +44 (0)20 3139 4830

PIN: 89662683#

 

 

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Jack Holden

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University, Oxford Instruments objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAFLEDSDSEAF
Date   Source Headline
1st Mar 20223:16 pmEQSForm 8.3 - The Vanguard Group, Inc.: Oxford Instruments PLC
1st Mar 20222:56 pmRNSForm 8.3 - Oxford Instruments plc
1st Mar 20222:42 pmGNWForm 8.3 - [Oxford Instruments plc - 28 02 2022] - (HHL)
1st Mar 20222:37 pmRNSForm 8.3 - [Oxford Instruments plc]
1st Mar 20222:24 pmRNSForm 8.3 - Spectris plc
1st Mar 20222:19 pmRNSForm 8.3 - Oxford Instruments plc
1st Mar 20222:13 pmRNSForm 8.3 - Oxford Instruments PLC
1st Mar 20221:54 pmGNWForm 8.3 - Oxford Instruments PLC
1st Mar 202212:49 pmRNSForm 8.5 (EPT/NON-RI) Oxford Instruments Plc
1st Mar 202212:41 pmRNSForm 8.3 - Oxford Instruments plc
1st Mar 202212:23 pmRNSForm 8.3 - Oxford Instruments Plc
1st Mar 202212:22 pmRNSForm 8.3 - Oxford Instruments plc
1st Mar 202212:16 pmRNSForm 8.3 - Spectris plc
1st Mar 202211:48 amRNSForm 8.3 - Oxford Instruments
1st Mar 202211:46 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - OXFORD INSTRUMENTS PLC - Ordinary Shares
1st Mar 202211:35 amRNSForm 8.5 (EPT/NON-RI)- Oxford Instruments plc
1st Mar 202211:29 amRNSForm 8.5 (EPT/RI)- Oxford Instruments plc
28th Feb 20225:31 pmRNSVoting rights and capital
28th Feb 20223:10 pmRNSStatement re Possible Offer
28th Feb 202211:58 amRNSStmnt re Share Price Movement
21st Feb 20222:21 pmPRNHolding(s) in Company
14th Feb 20229:35 amPRNDirector/PDMR Shareholding
24th Jan 20221:22 pmPRNHolding(s) in Company
11th Jan 20225:36 pmPRNDirector/PDMR Shareholding
7th Jan 202210:32 amPRNBlocklisting - Interim Review
13th Dec 202111:43 amPRNDirector/PDMR Shareholding
6th Dec 20213:31 pmPRNHolding(s) in Company
1st Dec 20212:29 pmPRNTotal Voting Rights
23rd Nov 20213:12 pmRNSHolding(s) in Company
11th Nov 20213:41 pmPRNDirector/PDMR Shareholding
9th Nov 20219:34 amRNSReplacement: Half-year Results
9th Nov 20217:00 amRNSHalf-year Results
2nd Nov 20218:54 amPRNDirector Declaration
12th Oct 202110:50 amPRNDirector/PDMR Shareholding
21st Sep 202112:44 pmRNSAnnual General Meeting 2021 results
21st Sep 20217:00 amRNSChairman’s AGM Statement 2021
13th Sep 20213:08 pmPRNDirector/PDMR Shareholding
1st Sep 20213:48 pmRNSCompletion of the Acquisition of WITec
1st Sep 202112:04 pmPRNTotal Voting Rights
12th Aug 20213:28 pmPRNDirector/PDMR Shareholding
10th Aug 20212:16 pmPRNDirector/PDMR Shareholding
4th Aug 20215:17 pmRNSPublication of Annual Report and Notice of AGM
2nd Aug 202111:48 amRNSAppointment of Independent Non-Executive Director
13th Jul 20213:40 pmPRNDirector/PDMR Shareholding
11th Jul 20216:15 pmPRNHolding(s) in Company
8th Jul 20219:35 amPRNDirectorate Change
7th Jul 202111:40 amPRNTotal Voting Rights
7th Jul 202111:28 amPRNBlocklisting - Interim Review
6th Jul 20217:59 amPRNDirector/PDMR Shareholding
25th Jun 20211:30 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.